Cargando…
Long-Term Outcomes of Switching from Fixed-Dose to As-Needed Regimen for Treating Submacular Hemorrhage Secondary to Polypoidal Choroidal Vasculopathy
Background: The aim of this study was to evaluate outcomes in patients with submacular hemorrhage secondary to polypoidal choroidal vasculopathy (PCV) after switching treatment from a fixed-dose to an as-needed regimen. Methods: This retrospective study included 19 patients with submacular hemorrhag...
Autores principales: | Kim, Jae Hui, Kim, Jong Woo, Kim, Chul Gu, Lee, Dong Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463565/ https://www.ncbi.nlm.nih.gov/pubmed/32823822 http://dx.doi.org/10.3390/jcm9082637 |
Ejemplares similares
-
Polypoidal Choroidal Vasculopathy in Korean Patients with Large Submacular Hemorrhage
por: Yoon, Jin Sook, et al.
Publicado: (2007) -
Visual Outcomes and Prognostic Factors of Large Submacular Hemorrhages Secondary to Polypoidal Choroidal Vasculopathy
por: Matsuo, Yu, et al.
Publicado: (2021) -
Submacular hemorrhage from polypoidal choroidal vasculopathy after cataract surgery
por: Tan, Colin S H, et al.
Publicado: (2013) -
Pneumatic displacement with intravitreal bevacizumab for massive submacular hemorrhage due to polypoidal choroidal vasculopathy
por: Kitahashi, Masayasu, et al.
Publicado: (2014) -
Successful delivery of subretinal aflibercept (new surgical technique) for the treatment of submacular hemorrhage in idiopathic polypoidal choroidal vasculopathy
por: Chalam, K V, et al.
Publicado: (2021)